Syros Pharmaceuticals (SYRS) Prices 5.4M Share Common Offering at $14/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
Go back to Syros Pharmaceuticals (SYRS) Prices 5.4M Share Common Offering at $14/Sh
January 19, 2021 5:44 PM EST
After-Hours Stock Movers:
Histogen Inc. (NASDAQ: HSTO) 16.5% LOWER; announced that the U.S. Food and Drug Administration (FDA) has verbally notified the company that it has additional questions about the companys Investigational New Drug (IND) application package for the planned Phase 1/2 clinical trial of HST-003, which is intended to evaluate the safety and efficacy of human extracellular matrix (hECM:HST-003) implanted within microfracture interstices and the cartilage defect in the knee to regenerate hyaline cartilage in combination with a microfracture procedure.
BioLineRx Ltd. (NASDAQ:... More
January 19, 2021 4:02 PM EST
Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, announced today that it is offering to sell shares of its common stock in an underwritten public offering. The proceeds of the offering are... More
